Jennifer L. Zachary
Net Worth

Last updated:

What is Jennifer L. Zachary net worth?

The estimated net worth of Ms. Jennifer L. Zachary is at least $45,949,053 as of 2 Feb 2024. She owns shares worth $2,467,811 as insider, has earned $32,741,242 from insider trading and has received compensation worth at least $10,740,000 in Merck & Co., Inc..

What is the salary of Jennifer L. Zachary?

Ms. Jennifer L. Zachary salary is $1,790,000 per year as Executive Vice President, Gen. Counsel & Corporation Sec. in Merck & Co., Inc..

How old is Jennifer L. Zachary?

Ms. Jennifer L. Zachary is 47 years old, born in 1978.

What stocks does Jennifer L. Zachary currently own?

As insider, Ms. Jennifer L. Zachary owns shares in one company:

Company Title Shares Price per share Total value
Merck & Co., Inc. (MRK) Executive Vice President, Gen. Counsel & Corporation Sec. 29,057 $84.93 $2,467,811

What does Merck & Co., Inc. do?

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

MRK logo
MRK
Merck & Co., Inc.
$84.93

Jennifer L. Zachary insider trading

Merck & Co., Inc.

Ms. Jennifer L. Zachary has made 5 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently she sold 49,499 units of MRK stock worth $6,284,789 on 2 Feb 2024.

The largest trade she's ever made was exercising 99,768 units of MRK stock on 28 Oct 2022. As of 2 Feb 2024 she still owns at least 29,057 units of MRK stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 49,499 $126.97 $6,284,789
Option
Stock Option (Right to Buy) 19,417 $87.1 $1,691,221
Option
Common Stock 19,417 $87.1 $1,691,221
Sale
Common Stock 19,141 $117.59 $2,250,828
Sale
Common Stock 75,436 $103.17 $7,782,732
Option
Stock Option (Right to Buy) 75,436 $56.04 $4,227,433
Option
Common Stock 75,436 $56.04 $4,227,433
Sale
Common Stock 99,768 $99.07 $9,884,016
Option
Stock Option (Right to Buy) 68,367 $77.62 $5,306,647
Option
Stock Option (Right to Buy) 51,884 $75.36 $3,909,978
Option
Stock Option (Right to Buy) 28,396 $73.73 $2,093,637
Option
Common Stock 68,367 N/A N/A
Option
Common Stock 51,884 N/A N/A
Option
Common Stock 28,396 N/A N/A
Sale
Common Stock 65,487 $99.85 $6,538,877
Option
Common Stock 5,772 $75.98 $438,557
Option
Restricted Stock Unit 5,772 $75.98 $438,557
Option
Common Stock 5,772 N/A N/A
Option
Restricted Stock Unit 5,772 N/A N/A
Option
Common Stock 5,772 N/A N/A
Option
Restricted Stock Unit 5,772 N/A N/A

Merck & Co. key executives

Merck & Co., Inc. executives and other stock owners filed with the SEC: